BTB Therapeutics, Inc. was originally founded in 2020 in Kyoto based on the transcriptomics drug discovery programs of Professor Masatoshi Hagiwara of Kyoto University. We are developing a non-opioid analgesic as a breakthrough modality to solve the opioid crisis. In addition, our pipeline includes RNA-modifying compounds to treat rare genetic diseases and to enhance the efficacy of cancer immunotherapy. We completed US corporate inversion in January 2025 and now BTB Therapeutics, Inc. is located in Escondido, CA with its operating subsidiary in Kyoto, Japan.
Company Details
- Employees
- 4
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.btbtherapeutics.com
- Keywords
- Los Angeles.
Btb Therapeutics, Inc. Questions
Btb Therapeutics, Inc.'s website is http://www.btbtherapeutics.com
Btb Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/btbtherapeutics
Btb Therapeutics, Inc. has
4 employees.
View email and phone details for 4
employees at Btb Therapeutics, Inc..
Btb Therapeutics, Inc.'s industry is
Biotechnology Research
Btb Therapeutics, Inc.'s top competitors are
Upyther,
Kyoto University Innovation Capital Co., Ltd,
Abbiotec,
Kaer Biotherapeutics Corporation,
Ventoux Biosciences,
Vasa Therapeutics,
Leaders Adapt,
Renova Therapeutics,
Okogen, Inc.,
Healthcare Innovation Catalysts.
Btb Therapeutics, Inc.'s categories are Biotechnology Research
Btb Therapeutics, Inc.'s founding year is 2024
